Entegris Inc vs Nuwellis Inc — how do they compare? Entegris Inc trades at $155.29 (market cap $22.95B), while Nuwellis Inc trades at $1.49 (market cap $542.80K). The key difference: Entegris Inc is far larger — about 42280.8× Nuwellis Inc's market cap, and Entegris Inc pays a 0.27% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| ENTG | NUWE | |
|---|---|---|
Market Cap | $22.95B | $542.80K |
Sector | Technology | Technology |
52-Week High | $184.00 | $220.50 |
52-Week Low | $68.80 | $1.42 |
Enterprise Value | $26.16B | -$1.27M |
Dividend Yield | 0.27% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Entegris Inc is a supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. The company's reportable segments include Specialty Chemicals & Engineered Materials (SCEM), Microcontamination Control (MC), and Advanced Materials Handling (AMH). The SCEM segment provides high-performance & high-purity process chemistries, gases, & materials, and safe & efficient delivery systems. The Microcontamination Control (MC) segment includes solutions to purify critical liquid chemistries and process gases used in semiconductor manufacturing processes and other high-technology industries. Its geographical segments are Taiwan, North America, South Korea, Japan, China, Europe, and Southeast Asia.
Read more on ENTG →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →